Form 4: Fulgent Genetics CEO Ming Hsieh Reports Share Transaction
SEC Form 4 Filing
Fulgent Genetics CEO Ming Hsieh reports disposition of shares to cover tax obligations and details beneficial ownership through trusts and custodial accounts.
Summary
- On May 23, 2024, Ming Hsieh, CEO of Fulgent Genetics, reported a transaction involving common stock.
- 2,111 shares were disposed of to satisfy tax withholding obligations related to vesting restricted stock units.
- Following the transaction, Hsieh directly owns 710,925 shares.
- Hsieh also has indirect ownership of 220,816 shares through the Dynasty Trust, 7,895,115 shares through The Ming Hsieh Trust, and 2,000 shares through Uniform Transfer to Minors Accounts.
- The transaction was reported on May 28, 2024.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing a routine transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common for executives of publicly traded companies. It provides transparency into the trading activities of key personnel.
Key Dates
| Date | Description |
|---|---|
| 02/23/2023 | Date of restricted stock units grant to the reporting person. |
| 02/27/2023 | Date the grant was originally reported on Form 4. |
| 05/23/2024 | Date of the reported transaction (disposal of shares). |
| 05/28/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.